Food Irradiation: FDA s Perspective Teresa Croce, Ph.D.

Similar documents
Ensuring Food and Feed Safety: US Food Law and FDA s Biotechnology Consultation Process

FDA Regulation of Food from GE Crops

CGMP Requirements for Investigational Products

Regulation of Microbiota- Based Products

Medical Devices; Neurological Devices; Classification of the Evoked Photon Image Capture

Agenda. - Introduction Howard Birndorf. - ASR Issues and the Draft ASR FAQ Guidance Patrick Balthrop

Reference Amount Customarily Consumed for Flavored Nut Butter Spreads and Products That

Medical Devices; Immunology and Microbiology Devices; Classification of the Nucleic Acid-

Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Cardiovascular

US FDA: CMC Issues for INDs

Office for Human Subject Protection. University of Rochester

Food Safety and Quality: Assessing the Impact of Biotechnology

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

US FDA Food Nanotechnology Guidelines: Where we are What is next. October 5, 2011

De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff

ECONOMIC IMPACT/ENVIRONMENTAL BENEFIT ANALYSIS

QSAR and Read-Across Approaches using in silico Tools in Food Ingredient/Contaminant Safety Assessments at the U.S. Food & Drug Administration

The GS1 System and services (GTIN, GLN and GDSN) can be used to comply with this rule.

Medical Devices; Exemptions From Premarket Notification: Class II Devices

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014

IVT Laboratory Week Jerry Lanese. Ph.D. The Lanese Group, Inc The Lanese Group, Inc.

CANADA (HEALTH CANADA)

IS THE US FDA REGULATION AND EVALUATION OF GENETICALLY ENGINEEERED FOODS SUFFICIENT? Teresa Marek FOOD REGULATION IN THE UNITED STATES

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011

EU and FDA GMP Regulations: Overview and Comparison

Medical Devices; Immunology and Microbiology Devices; Classification of the Automated

(EFSA-Q ) 1 For the purpose of this document foods of animal origin are limited to fresh unprocessed products of animal origin.

Expanded Access and the Individual Patient IND

Colorants in Medical Devices:

Advanced Surgical Concepts, Ltd. Jonathan Kahan Hogan Lovells US LLP Columbia Square 555 Thirteenth Street, NW Washington, DC 20004

National Bioengineered Food Disclosure Standard. Dr. Craig Morris Deputy Administrator AMS Livestock, Poultry, and Seed Program

REGULATORY ISSUES: HOW TO APPLY FOR AN IND. Penny Jester and Maaike Everts

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness

FDA's Initiative to Regulate Lab- Developed Tests (LDT) will Harm Patients and Academic Pathology

Presentation Outline

H-20 Page 1 of 5. Institutional Review Board Policy Manual HUMANITARIAN USE DEVICE (HUD) REQUIREMENTS

E-beam Treatment of Toxic Wastes; The Experiences in Pilot and Industrial Scale Plant

FDA s Final Rule on Medical Device Data Systems Signals Active Regulation of Data Communication Technologies

Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products Guidance for Industry

January 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

Guidance for Industry

SUBJECT: INSTITUTIONAL REVIEW BOARD (IRB) - HUMANITARIAN USE DEVICES

Food Tech: New Tech. What You Need to Know! FOOD IRRADIATION

Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act

BSc (Hons) Food Science and Technology - A304

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

November 15, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852

Early Development Best Practices for Stability- Regulatory Perspective

September 16, Via Electronic Submission

9/24/2012. Science Symposium FDA, Nanotechnology and Cosmetics Jay Ansell, PhD., DABT AGENDA

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Document issued on: March 19, The draft of this document was issued on May 20, 2010.

Clarifying digital health and software regulation: FDA releases three new guidance documents

Docket No. FDA-2015-D-3990 Sunscreen Innovation Act: Section 586C(c) Advisory Committee

Navigating an FDA GMP and Validation Inspection- Best Practices and Pitfalls

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

The Food Safety Modernization Act and Its Implications for USDA and Dual Jurisdiction Establishments

The Intersection of Genomics Research and the IDE Regulation

Research Scientist (Various Specialties) Series

21 CFR Ch. I ( Edition) Personnel Design controls Identification Traceability.

Food and Drug Administration Reauthorization Act of 2017

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Reprocessing of Medical Devices: Concerns about Sharps

ASTM D10-F02 Workshop FDA Regulatory Perspective. Patrick Weixel FDA Center for Devices and Radiological Health

STIMULI TO THE REVISION PROCESS

Title: Department: Approved by: Director, Human Research Review and Compliance

Safety and Performance Grading of Quality Management System Nonconformities

Biodegradable Certification Standard

MEMORANDUM Via

Guidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy

Moderator: Rob Long, Long s Family Farm and Orchard, Commerce Township, MI

2013 May expect UDI Final Rule. This put a date on when the draft of the proposed rule had to be released

The Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Determination of IND/IDE Requirement

Molecular Diagnostics: The Shift to Complexity. Molecular Diagnostics Regulation: Where do we go from here? David W Feigal, Jr.

Combination Products at US FDA

Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite Connecticut Ave., NW Washington, DC, D

IAEA SAFETY STANDARDS for protecting people and the environment. Predisposal Management of Radioactive Waste from Nuclear Fuel Cycle Facilities

AUDIT COMMITTEE CHARTER

Pesticide Residue Issues in California: Is Our Food Safe?

Quality Manual. Index

Updates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc.

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

CDRH Device Approval

Produce Safety Challenges & Opportunities. Jim Gorny, Ph.D. Vice President of Food Safety & Technology

Food and Drug Administration (FDA) 101

FSMA and Grain Handlers

Under this license, you are approved to manufacture aflibercept drug substance intermediate, drug substance, and formulated bulk at

THE CALIFORNIA RIGHT TO KNOW GENETICALLY ENGINEERED FOOD ACT

Radiation Protection of the Public and Protection of the Environment

An FDA Perspective on Atypical Active Ingredients

Proposed Amendments to the Toxic Substances Control Act (TSCA): Senate and House Bills Compared with Current Law

THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES

Public Procurement Act

US FOOD SAFETY MODERNIZATION ACT (FSMA) IMPACTS ON GLOBAL FOOD TRADE, CAPACITY BUILDING AND TRAINING

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

While comprehensive, this document does not replace a thorough review of the Rule to assure proper compliance.

Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval

Introduction to Clinical Research

Defining Clinical Benefit in Clinical Trials: FDA Perspective

Transcription:

Food Irradiation: FDA s Perspective Teresa Croce, Ph.D. Office of Food Additive Safety Center for Food Safety and Applied Nutrition US Food and Drug Administration March 23, 2016

Federal Food, Drug, & Cosmetic (FD&C) Act Food Additives Amendment 1958 Defines food additive (w/ GRAS exemption) Requires premarket approval of new uses of food additives, if not GRAS or otherwise exempt from the definition Establishes the standard of data review Establishes the standard of safety Establishes formal rulemaking procedures Food additive regulations are located in Title 21 of the U.S. Code of Federal Regulations (21 CFR) 2

FDA s Authority Over Sources of Radiation Used to Treat Food Section 201(s) of the FD&C Act defines the term food additive to include any source of radiation intended for any such use Foods containing unapproved food additives are considered adulterated under section 402 of the Act Section 402(a)(7) a food shall be deemed adulterated if it has been intentionally subjected to radiation, unless the use of radiation was in conformity with a regulation or exemption in effect pursuant to section 409... 3

Basics of the Food Additive Petition Process FD&C Act requires premarket review of food additives Safety Standard: Reasonable certainty of no harm Petitioner: Burden to establish the safety of a proposed use FDA: Responsible for conducting a full and fair evaluation Food additive petition requirements are found in Title 21 of the Code of Federal Regulations, Part 171.1 (21 CFR 171.1) An interested party petitions FDA FDA reviews the data submitted FDA makes a determination of safety Results in a regulation in 21 CFR 4

Safety Considerations for Evaluating Sources of Radiation Used to Treat Food Assess the impacts of ionizing radiation on: Safety of Radiolytic Products Chemical Composition Potential Toxicity Nutritional Adequacy Changes in Microbiological Profile SAFE? 5

Safety of Radiolytic Products: Impacts on Chemical Composition Radiation-induced chemical reactions: Influenced by physical state of the food (solid, liquid, dry, or frozen) and dose Extent of chemical changes are greater when water or oxygen is present Radiolytic products formed are generally similar to chemicals produced during heating of food Petition should address the chemical changes resulting from the petitioned use of ionizing radiation 6

Safety of Radiolytic Products: Potential Toxicity Some chemicals may be formed that are of toxicological concern at high doses These chemicals are also found in non-irradiated food at similar or higher concentrations (e.g., furan, alkylcyclobutanones) Hundreds of toxicology studies have been assessed No effects noted in most studies Studies that reported effects are mainly due to dietary deficiencies (i.e., abnormal diet for the animal) Toxicology data for a treated food may be applied to the toxicological evaluation of a different, treated food of a similar generic class 7

Nutritional Adequacy Minerals are not affected by ionizing radiation Irradiation of macronutrients has been well-studied Protein Lipid Carbohydrates (to a lesser extent) Micronutrients are evaluated on a case-by-case basis due to variable sensitivity under different conditions Nutrient losses are considered in the context of the total diet 8

Microbiological Considerations General microbiological considerations: Sensitivity of the microorganism to ionizing radiation varies by species and with the environment Petition should identify and address the pathogen of public health significance, if appropriate Specific microbiological considerations for phytosanitary use: Dose levels above 1 kgy have the ability to affect the spoilage microorganisms 9

Other Considerations: Scope Image www.gandsorchards.com Image www.wisegeek.org Increasing Complexity Image sciencedaily.com 10

Other Considerations: Labeling As a condition of use, FDA requires that foods treated with ionizing radiation bear the radura label and must state on the label Treated with radiation or Treated by irradiation 11

Other Considerations: Packaging Food should be packaged prior to treatment with ionizing radiation in a way to limit recontamination Not all food will be contained in closed packaging (e.g., fruit) Packaging subjected to ionizing radiation incidental to the treatment of food shall be in compliance with one of the following: 21 CFR 179.45 A threshold of regulation (TOR) exemption under 21 CFR 170.39 An effective food contact notification 12

Petition for a New Use of Ionizing Radiation: Data Needed to Support Safety Determination Information relied upon may be: Data generated by the petitioner Data generated by a contract lab Literature in peer-reviewed journals Data in FDA s files obtained through a Freedom of Information (FOI) Act request Other sources Data obtained on a food under specific conditions may be extrapolated to draw conclusions regarding the safety of similar food treated with ionizing radiation under similar conditions 13

Pre-Submission Consultations OFAS encourages pre-submission consultations, including meetings, to facilitate the development of submissions Draft petitions may be shared with OFAS Pre-submissions may be used: To verify whether a submission is required to a certain program; To determine whether the quality and quantity of information is adequate; When there are uncertainties on how certain data may be interpreted; or To assess a study protocol We recommend petitioners consult with OFAS prior to initiating studies 14

Resources FDA s website (fda.gov): Webpage for Food Irradiation: http://www.fda.gov/food/ingredientspackaginglabeling/irradiatedfood Packaging/default.htm The Electronic Code of Federal Regulations (see Title 21, Part 179) www.ecfr.gov Contact Information: teresa.croce@fda.hhs.gov 15